Literature DB >> 23597050

Melatonin deficiency hypothesis in delirium: a synthesis of current evidence.

Sophia E de Rooij1, Barbara C van Munster.   

Abstract

The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm in many mammals, including humans. Patients with acute confusional state or delirium, especially those with underlying cognitive impairment, frequently suffer from sleep disturbances and disturbed circadian rhythm. In this review, an overview is given of delirium and delirium symptoms that correspond with symptoms in dementia, such as sundowning, followed by a presentation of the circadian rhythm disorders in delirium in relation to melatonin deficiency. Finally, this review examines the therapeutic benefit of melatonin treatment in disorders related to delirium and dementia, including the placebo-controlled randomized clinical trials addressing this topic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597050     DOI: 10.1089/rej.2012.1405

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  14 in total

1.  Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.

Authors:  Ta-Chuan Yeh; Chin-Bin Yeh; Nian-Sheng Tzeng; Wei-Chung Mao
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

2.  Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials.

Authors:  Sheng Chen; LiGen Shi; Feng Liang; Liang Xu; Doycheva Desislava; Qun Wu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-07-21       Impact factor: 5.590

3.  Report and Research Agenda of the American Geriatrics Society and National Institute on Aging Bedside-to-Bench Conference on Sleep, Circadian Rhythms, and Aging: New Avenues for Improving Brain Health, Physical Health, and Functioning.

Authors:  Constance H Fung; Michael V Vitiello; Cathy A Alessi; George A Kuchel
Journal:  J Am Geriatr Soc       Date:  2016-11-14       Impact factor: 5.562

4.  Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial.

Authors:  Annemarieke de Jonghe; Barbara C van Munster; J Carel Goslings; Peter Kloen; Carolien van Rees; Reinder Wolvius; Romuald van Velde; Marcel Levi; Rob J de Haan; Sophia E de Rooij
Journal:  CMAJ       Date:  2014-09-02       Impact factor: 8.262

Review 5.  Prevention of Post-operative Delirium in the Elderly Using Pharmacological Agents.

Authors:  Patrice Tremblay; Susan Gold
Journal:  Can Geriatr J       Date:  2016-09-30

6.  Assessment of Melatonergics in Prevention of Delirium: A Systematic Review and Meta-Analysis.

Authors:  Yibing Zhu; Zhiming Jiang; Huibin Huang; Wen Li; Chao Ren; Renqi Yao; Yang Wang; Yongming Yao; Wei Li; Bin Du; Xiuming Xi
Journal:  Front Neurol       Date:  2020-04-07       Impact factor: 4.003

Review 7.  Delirium diagnosis, screening and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Curr Opin Support Palliat Care       Date:  2014-09       Impact factor: 2.302

8.  The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.

Authors:  Shirley Harvey Bush; Nathalie Lacaze-Masmonteil; Marie Theresa McNamara-Kilian; Alistair Richard MacDonald; Sallyanne Tierney; Franco Momoli; Meera Agar; David Christopher Currow; Peter Gerard Lawlor
Journal:  Trials       Date:  2016-08-11       Impact factor: 2.279

9.  Melatonin and the Prevention and Management of Delirium: A Scoping Study.

Authors:  Sin Wei Choy; Aun Chian Yeoh; Zhao Zheng Lee; Velandai Srikanth; Chris Moran
Journal:  Front Med (Lausanne)       Date:  2018-01-08

10.  Effects of Ramelteon on the Prevention of Postoperative Delirium in Older Patients Undergoing Orthopedic Surgery: The RECOVER Randomized Controlled Trial.

Authors:  Esther S Oh; Jeannie-Marie Leoutsakos; Paul B Rosenberg; Alexandra M Pletnikova; Harpal S Khanuja; Robert S Sterling; Julius K Oni; Frederick E Sieber; Neal S Fedarko; Narjes Akhlaghi; Karin J Neufeld
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-16       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.